The measurement properties of EQ-5D-5L among patients with low back pain receiving traditional Chinese non-pharmacological therapies in China

Traditional Chinese non-pharmacological therapies have shown potential in reducing analgesic use in low back pain (LBP) management. However, few studies have examined the performance of the most commonly used generic preference-based measure, the EQ-5D-5L, for traditional Chinese non-pharmacological therapies. This study aimed to assess its performance among patients with LBP receiving such therapies in China. The EQ-5D-5L, the Oswestry Disability Index (ODI) and the Quebec Back Pain Disability Scale (QBPDS) were collected before and after an episode of traditional Chinese non-pharmacological therapies. EQ-5D-5L’s ceiling and flooring effects, convergent validity, known-group validity (grouped by gender, age and pain level) and informativity (Shannon [H’] and Shannon evenness [J’] indices) were assessed at baseline. After treatment, individuals who completed the assessment were categorized into 4 subgroups against the change of ODI ( n = 150). EQ-5D-5L’s responsiveness was assessed using effect size (ES), standardized response mean (SRM) and Guyatt’s Responsiveness Index (GRI). A total of 350 individuals were recruited at baseline (average age 49.51 ± 16.17 years, 57.4% female), among which 150 individuals completed the EQ-5D-5L after treatment. EQ-5D-5L showed no ceiling or floor effects. Regarding the convergent validity, correlation coefficients between EQ dimensions and ODI ranged from 0.60 to 0.81, 0.48 to 0.82 for QBPDS. The hypothesises of known-group analysis was confirmed among pre-defined groups. Informativity for each EQ-5D-5L dimension were excellent (H’,1.93 to 2.09, J’, 0.83 to 0.90). The responsiveness for each improvement subgroup was good (ES: 1.65–6.49, SRM: 1.76–6.40, GRI: 1.91 to 6.18). Our study provided evidence that EQ-5D-5L may be a suitable health-related quality of life measure for LBP patients receiving traditional Chinese non-pharmacological therapies and indicated that it could be useful for economic evaluations in this context.

Authors

Institutions

Publication Details

Journal
BMC Complementary Medicine and Therapies
Published
2026-11-18
DOI
https://doi.org/10.1186/s12906-026-05675-x
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The measurement properties of EQ-5D-5L among patients with low back pain receiving traditional Chinese non-pharmacological therapies in China

Jiabi Wen, Xuejing Jin, Qianji Chen, Changhe Yu et al.
BMC Complementary Medicine and Therapies
Health Systems, Economic Evaluations, Quality of Life
article

The measurement properties of EQ-5D-5L among patients with low back pain receiving traditional Chinese non-pharmacological therapies in China

Jiabi Wen, Xuejing Jin, Qianji Chen, Changhe Yu, Yixuan Gao, Xiaoquan Li, Ya’nan Sun, Lining Zhang
article en

Abstract

Traditional Chinese non-pharmacological therapies have shown potential in reducing analgesic use in low back pain (LBP) management. However, few studies have examined the performance of the most commonly used generic preference-based measure, the EQ-5D-5L, for traditional Chinese non-pharmacological therapies. This study aimed to assess its performance among patients with LBP receiving such therapies in China. The EQ-5D-5L, the Oswestry Disability Index (ODI) and the Quebec Back Pain Disability Scale (QBPDS) were collected before and after an episode of traditional Chinese non-pharmacological therapies. EQ-5D-5L’s ceiling and flooring effects, convergent validity, known-group validity (grouped by gender, age and pain level) and informativity (Shannon [H’] and Shannon evenness [J’] indices) were assessed at baseline. After treatment, individuals who completed the assessment were categorized into 4 subgroups against the change of ODI ( n = 150). EQ-5D-5L’s responsiveness was assessed using effect size (ES), standardized response mean (SRM) and Guyatt’s Responsiveness Index (GRI). A total of 350 individuals were recruited at baseline (average age 49.51 ± 16.17 years, 57.4% female), among which 150 individuals completed the EQ-5D-5L after treatment. EQ-5D-5L showed no ceiling or floor effects. Regarding the convergent validity, correlation coefficients between EQ dimensions and ODI ranged from 0.60 to 0.81, 0.48 to 0.82 for QBPDS. The hypothesises of known-group analysis was confirmed among pre-defined groups. Informativity for each EQ-5D-5L dimension were excellent (H’,1.93 to 2.09, J’, 0.83 to 0.90). The responsiveness for each improvement subgroup was good (ES: 1.65–6.49, SRM: 1.76–6.40, GRI: 1.91 to 6.18). Our study provided evidence that EQ-5D-5L may be a suitable health-related quality of life measure for LBP patients receiving traditional Chinese non-pharmacological therapies and indicated that it could be useful for economic evaluations in this context.

BMC Complementary Medicine and Therapies
University of Alberta (CA), Beijing University of Chinese Medicine (CN), Capital Medical University (CN), Xuan Wu Hospital of the Capital Medical University (CN), Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN), Shenyang 242 Hospital (CN)
National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Good health and well-being
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon